The company expects 2025 organic revenue growth of 3%-7%, excluding the wind-down of certain product lines. GN Hearing anticipates 5%-9% growth, supported by new launches like ReSound Vivia and Savi.
The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...
The FDA regulates what can and can't be called a hearing aid, but that doesn't mean your Samsung Galaxy Buds won't work as a ...
Hearing implants, such as cochlear implants through UCHealth and Cochlear Osia by Cochlear Americas, can help address ...
4d
Interesting Engineering on MSNUS FDA approves first-ever smart glasses with hearing aid for mild to moderate lossIn a significant advancement in hearing and vision solutions, EssilorLuxottica has announced that its Nuance Audio Glasses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results